WASHINGTON - President Donald Trump on Thursday unleashed a fresh round of punishing tariffs on a broad range of imported goods, saying the U.S. will impose 100% duties on branded drugs and 25% ...
A private investigator looking into the death of 15-year-old Celeste Rivas says he discovered unusual tools in D4vd's former rental home in the Hollywood Hills. In a new interview, Los Angeles-based ...
US President Donald Trump on Monday announced that his administration will impose 25 per cent tariffs on all medium and heavy-duty imported trucks coming into the United States from other countries, ...
This story was reported by Tory N. Parrish, James T. Madore and Brianne Ledda. It was written by Parrish. Newly announced tariffs on upholstered furniture, medication and heavy-duty trucks are leading ...
Ford CEO Jim Farley has responded to President Donald Trump's new tariffs on overseas heavy trucks, calling it "a really big deal for our country, and for Ford." The Trump administration announced ...
A 25% tariff on imported heavy-duty trucks is set to take effect October 1, potentially raising vehicle costs and prompting shifts in manufacturing locations. Major OEMs Daimler, Paccar, Volvo, and ...
President Donald Trump on Thursday announced a new round of punishing tariffs, saying the United States will impose a 100% tariff on imported branded drugs, 25% tariff on imports of all heavy-duty ...
Transform your DIY workspace with the ultimate heavy-duty mobile workbench! Featuring a 52" x 25" size, 9 spacious drawers, a matte black finish, and an adjustable-heighthardwood top — perfect for all ...
WASHINGTON (Reuters) -The Trump administration plans to issue rules to restrict or potentially bar imports of Chinese drones and medium and heavy-duty vehicles after an earlier crackdown on cars and ...
Heavy Duty Trucking’s Truck Fleet Innovators for 2025 are five executives who are leading the industry in technology adoption, process improvement, safety, sustainability, and more. Since 2006, the ...
– Zanzalintinib in combination with atezolizumab demonstrated a statistically significant reduction in risk of death versus regorafenib in intent-to-treat population – ALAMEDA, Calif., June 22, 2025-- ...
Merck, known as MSD outside of the United States and Canada, announced today safety and efficacy results from the open-label phase 1 KANDLELIT-001 study, a clinical trial evaluating MK-1084, an ...